GGrantIndex
Sort

326,823 grants matching clinical trial

Topological Mapping of Immune, Microbiota, Metabolomic and Clinical Phenotypes to Reveal ME/CFS Disease Mechanisms

$2,118,412
Derya Unutmaz · Jackson Laboratory · U54 · FY2020 · NS

Center for Pre-Clinical Cancer Research

$2,118,025
Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2024 · GM

The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer

$2,117,925
Robert C Bast · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA

Clinical and Behavioral Phenotyping of Autism and Related Disorders

$2,117,811
Susan Swedo · National Institute Of Mental Health · ZIA · FY2011 · MH

Specialized Program Of Research Excellence (SPORE) in Leukemia.

$2,117,606
Daniel C Link · Washington University · P50 · FY2019 · CA

Childhood Liver Disease Research Network Data Coordinating Center

$2,117,585
John C Magee · University Of Michigan At Ann Arbor · U01 · FY2017 · DK

WHI Sequencing Project (WHISP)

$2,117,232
Rebecca D Jackson · Ohio State University · RC2 · FY2009 · HL

Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) Network

$2,117,150
Mark J Kupersmith · St. Luke'S-Roosevelt Inst For Hlth Scis · U10 · FY2011 · EY

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$2,117,028
Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Cancer Center Support Grant

$2,116,924
Robert S. Dipaola · Rbhs -Cancer Institute Of New Jersey · P30 · FY2013 · CA

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,116,878
Anantha Shekhar · Indiana University Indianapolis · UL1 · FY2010 · RR

Immunopathogenesis of Fungal Infections

$2,116,544
Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

SPORE in Breast Cancer

$2,116,400
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA

Contraception development research center to advance a novel intravaginal ring as a non-hormonal multipurpose prevention technology

$2,116,301
Lisa Blake Haddad · Population Council · P50 · FY2023 · HD

AAV Gene Therapy for Lipid Disorders

$2,116,284
James M Wilson · University Of Pennsylvania · P01 · FY2015 · HL

Translational Hearing Center

$2,116,006
Peter S Steyger · Creighton University · P20 · FY2023 · GM

Optimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization

$2,115,968
Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2022 · DA

ProNET: Psychosis-Risk Outcomes Network

$2,115,894
Scott W Woods · Yale University · U01 · FY2021 · MH

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$2,115,683
Nigel H. Greig · National Institute On Aging · ZIA · FY2020 · AG

Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments

$2,115,615
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

HIV PREVENTION TRIAL UNITS

$2,115,542
Fenway Community Health Center · U01 · FY2003 · AI

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

$2,115,352
Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

$2,115,286
Kelan G Tantisira · University Of California, San Diego · R01 · FY2022 · HL

Administrative Core

$2,115,278
Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG

Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens

$2,115,203
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI